The stop-work order on USAID-funded research has left thousands of people with experimental drugs or devices in their bodies, ...

When growing gang violence and the kidnappings of healthcare workers forced Haiti’s leading organization in the treatment of HIV and AIDS-related illnesses to relocate operations from its main site in ...

Merck Sharp & Dohme LLC has identified targeted activator of cell kill (TACK) compounds acting as Gag polyprotein (HIV-1)/protein Pol dimerization inducers reported to be useful for the treatment of ...

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with daily use of the nonsteroidal anti-inflammatory pill celecoxib, new research ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

PEPFAR has saved 25 million lives around the globe and is considered George W. Bush's greatest achievement. Donald Trump has left its future in doubt.

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders – T cells – lose their ability to function effectively.

HIV is "like a time bomb," said James Riley, a microbiologist at University of Pennsylvania, US. Even now — decades after the virus was identified — and with antiretroviral drugs allowing us to ...